Next Article in Journal
Nanoparticles in Sentinel Lymph Node Assessment in Breast Cancer
Next Article in Special Issue
Molecular Pathogenesis of Pancreatic Neuroendocrine Tumors
Previous Article in Journal
NF-κB in T-cell Acute Lymphoblastic Leukemia: Oncogenic Functions in Leukemic and in Microenvironmental Cells
Previous Article in Special Issue
Pancreatic Cancer Biomarkers and Their Implication in Cancer Diagnosis and Epidemiology
Open AccessReview

Familial Pancreatic Cancer

1
Department of Preventive Medicine and Public Health, Creighton University, 2500 California Plaza, Omaha NE 68178, USA
2
Department of Gastroenterology, Creighton University, 2500 California Plaza, Omaha NE 68178, USA
*
Author to whom correspondence should be addressed.
Cancers 2010, 2(4), 1861-1883; https://doi.org/10.3390/cancers2041861
Received: 12 October 2010 / Revised: 3 November 2010 / Accepted: 4 November 2010 / Published: 10 November 2010
(This article belongs to the Special Issue Pancreatic Cancer)
Pancreatic cancer’s high mortality rate equates closely with its incidence, thereby showing the need for development of biomarkers of its increased risk and a better understanding of its genetics, so that high-risk patients can be better targeted for screening and early potential lifesaving diagnosis. Its phenotypic and genotypic heterogeneity is extensive and requires careful scrutiny of its pattern of cancer associations, such as malignant melanoma associated with pancreatic cancer, in the familial atypical multiple mole melanoma syndrome, due to the CDKN2A germline mutation. This review is designed to depict several of the hereditary pancreatic cancer syndromes with particular attention given to the clinical application of this knowledge into improved control of pancreatic cancer. View Full-Text
Keywords: phenotypic and genotypic heterogeneity; high mortality; genetic counseling; biomarker paucity; FAMMM syndrome; Li-Fraumeni syndrome; Lynch syndrome; pancreatic cancer phenotypic and genotypic heterogeneity; high mortality; genetic counseling; biomarker paucity; FAMMM syndrome; Li-Fraumeni syndrome; Lynch syndrome; pancreatic cancer
Show Figures

Figure 1

MDPI and ACS Style

Lynch, H.T.; Lynch, J.F.; Lanspa, S.J. Familial Pancreatic Cancer. Cancers 2010, 2, 1861-1883. https://doi.org/10.3390/cancers2041861

AMA Style

Lynch HT, Lynch JF, Lanspa SJ. Familial Pancreatic Cancer. Cancers. 2010; 2(4):1861-1883. https://doi.org/10.3390/cancers2041861

Chicago/Turabian Style

Lynch, Henry T.; Lynch, Jane F.; Lanspa, Stephen J. 2010. "Familial Pancreatic Cancer" Cancers 2, no. 4: 1861-1883. https://doi.org/10.3390/cancers2041861

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Search more from Scilit
 
Search
Back to TopTop